Home >> General Pharmaceuticals >> Housing >> Food & Beverage >>

Hyperlipidemia Global Clinical Trials Review, H1, 2014

Published: Apr-2014 | Format: PDF | GlobalData | Number of pages: 120 | Code: MRS - 24136


GlobalData's clinical trial report, "Hyperlipidemia Global Clinical Trials Review, H1, 2014" provides data on the Hyperlipidemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Hyperlipidemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Hyperlipidemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

Table of Contents 2
List of Tables 4
List of Figures 5

Introduction 6
Hyperlipidemia 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Five Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Hyperlipidemia 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Hyperlipidemia Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Hyperlipidemia 34
Mar 30, 2014: Data From Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins 34
Mar 19, 2014: Isis Pharmaceuticals Initiates Phase 1 Study of ISIS-ANGPTL3 Rx to Treat Hyperlipidemia 36
Feb 26, 2013: Merck's Niacin-Statin Combination Significantly Increases Adverse Side-effects, Phase III Study Shows 36
Jan 15, 2013: Mochida Pharma Announces Phase II Results Of Epadel For Treatment Of Hyperlipidemia And Arteriosclerosis Obliterans 37
Nov 05, 2012: Roche's Dalcetrapib Increases HDL Levels But Fails To Reduce Risk Of Cardiovascular Events, Study Finds 38
Clinical Trial Profiles 39
Clinical Trial Overview of Top Companies 39
Pfizer Inc. 39
Clinical Trial Overview of Pfizer Inc. 39
Merck & Co., Inc. 42
Clinical Trial Overview of Merck & Co., Inc. 42
AstraZeneca PLC 44
Clinical Trial Overview of AstraZeneca PLC 44
Abbott Laboratories 46
Clinical Trial Overview of Abbott Laboratories 46
Amgen Inc. 47
Clinical Trial Overview of Amgen Inc. 47
Kowa Company, Ltd. 48
Clinical Trial Overview of Kowa Company, Ltd. 48
HanAll Biopharma Co., Ltd. 49
Clinical Trial Overview of HanAll Biopharma Co., Ltd. 49
Daiichi Sankyo Company, Limited 50
Clinical Trial Overview of Daiichi Sankyo Company, Limited 50
Hanmi Science Co., Ltd. 51
Clinical Trial Overview of Hanmi Science Co., Ltd. 51
Cipher Pharmaceuticals Inc. 52
Clinical Trial Overview of Cipher Pharmaceuticals Inc. 52
Clinical Trial Overview of Top Institutes / Government 53
University of Toronto 53
Clinical Trial Overview of University of Toronto 53
National Heart, Lung, and Blood Institute 54
Clinical Trial Overview of National Heart, Lung, and Blood Institute 54
Central South University 55
Clinical Trial Overview of Central South University 55
University of Manitoba 56
Clinical Trial Overview of University of Manitoba 56
U.S. Department of Veterans Affairs 57
Clinical Trial Overview of U.S. Department of Veterans Affairs 57
Stanford University 58
Clinical Trial Overview of Stanford University 58
Emory University 59
Clinical Trial Overview of Emory University 59
The Ohio State University 60
Clinical Trial Overview of The Ohio State University 60
University of Colorado 61
Clinical Trial Overview of University of Colorado 61
Hiroshima University Hospital 62
Clinical Trial Overview of Hiroshima University Hospital 62
Five Key Clinical Profiles 63

Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 119
Secondary Research 119
About GlobalData 120
Contact Us 120
Disclaimer 120
Source 120

List of Tables

Hyperlipidemia Therapeutics, Global, Clinical Trials by Region, 2014* 7
Hyperlipidemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperlipidemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperlipidemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Hyperlipidemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Hyperlipidemia Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Hyperlipidemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2014* 13
Hyperlipidemia Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2014* 14
Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperlipidemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperlipidemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperlipidemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperlipidemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperlipidemia Therapeutics, Global, Clinical Trials by Phase, 2014* 21
Hyperlipidemia Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 22
Hyperlipidemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperlipidemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hyperlipidemia Therapeutics, Global, Suspended Clinical Trials, 2014* 25
Hyperlipidemia Therapeutics, Global, Withdrawn Clinical Trials, 2014* 25
Hyperlipidemia Therapeutics, Global, Terminated Clinical Trials, 2014* 26
Hyperlipidemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Hyperlipidemia Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 29
Hyperlipidemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Hyperlipidemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 32
Hyperlipidemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2014* 39
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2014* 42
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2014* 44
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2014* 46
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Amgen Inc., 2014* 47
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kowa Company, Ltd., 2014* 48
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by HanAll Biopharma Co., Ltd., 2014* 49
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Daiichi Sankyo Company, Limited, 2014* 50
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hanmi Science Co., Ltd., 2014* 51
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cipher Pharmaceuticals Inc., 2014* 52
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Toronto, 2014* 53
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by National Heart, Lung, and Blood Institute, 2014* 54
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Central South University, 2014* 55
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Manitoba, 2014* 56
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by U.S. Department of Veterans Affairs, 2014* 57
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Stanford University, 2014* 58
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Emory University, 2014* 59
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2014* 60
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Colorado, 2014* 61
Hyperlipidemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hiroshima University Hospital, 2014* 62

List of Figures

Hyperlipidemia Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Hyperlipidemia Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Hyperlipidemia Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Hyperlipidemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Hyperlipidemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Hyperlipidemia Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Hyperlipidemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2014* 13
Hyperlipidemia Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2014* 14
Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials, G7 Countries (%), 2014* 15
Hyperlipidemia Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 16
Hyperlipidemia Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 17
Proportion of Hyperlipidemia to Metabolic Disorders Clinical Trials, E7 Countries (%), 2014* 18
Hyperlipidemia Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 19
Hyperlipidemia Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 20
Hyperlipidemia Therapeutics, Global, Clinical Trials by Phase (%), 2014* 21
Hyperlipidemia Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 22
Hyperlipidemia Therapeutics, Global, Clinical Trials by Trial Status, 2014* 23
Hyperlipidemia Therapeutics Clinical Trials, Global, by End Point Status, 2014* 24
Hyperlipidemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 28
Hyperlipidemia Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 29
Hyperlipidemia Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 30
Hyperlipidemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 31
Hyperlipidemia Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 33
GlobalData Methodology 119

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)2500 View Pricing